Sarah Boyce - President and CEO, Director at Avidity Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
RNA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sarah Boyce - trading volume in the past year for Avidity Biosciences, Inc.

Holdings reported by Sarah Boyce for Avidity Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 265K $8.66M $32.66 Dec 18, 2024 Direct
Stock Option (Right to Buy) 461K Aug 6, 2024 Direct Common Stock

Transactions reported by Sarah Boyce for Avidity Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.